In this study, we demonstrate that mYGJ inhibits HSC-T6 hepatic stellate cell proliferation concomitant with a significant decrease in the expression of liver fibrosis marker α-SMA. The gene discussed is ACTA1; the disease is Hepatic fibrosis.